These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22026148)

  • 21. T cell recognition of non-peptidic antigens in infectious diseases.
    Singhal A; Mori L; De Libero G
    Indian J Med Res; 2013 Nov; 138(5):620-31. PubMed ID: 24434317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response.
    Schamel WW; Arechaga I; Risueño RM; van Santen HM; Cabezas P; Risco C; Valpuesta JM; Alarcón B
    J Exp Med; 2005 Aug; 202(4):493-503. PubMed ID: 16087711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Enriched T Cell Epitope Specificity in Full T Cell Receptor Sequence Repertoires.
    Gielis S; Moris P; Bittremieux W; De Neuter N; Ogunjimi B; Laukens K; Meysman P
    Front Immunol; 2019; 10():2820. PubMed ID: 31849987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
    Nolan KF; Yun CO; Akamatsu Y; Murphy JC; Leung SO; Beecham EJ; Junghans RP
    Clin Cancer Res; 1999 Dec; 5(12):3928-41. PubMed ID: 10632322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell-mediated antigen presentation: a potential mechanism of infectious tolerance.
    Mannie MD
    Immunol Res; 2001; 23(1):1-21. PubMed ID: 11417857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiretroviral therapy reduces the magnitude and T cell receptor repertoire diversity of HIV-specific T cell responses without changing T cell clonotype dominance.
    Conrad JA; Ramalingam RK; Duncan CB; Smith RM; Wei J; Barnett L; Simons BC; Lorey SL; Kalams SA
    J Virol; 2012 Apr; 86(8):4213-21. PubMed ID: 22258246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deciphering CD4
    Kisielow J; Obermair FJ; Kopf M
    Nat Immunol; 2019 May; 20(5):652-662. PubMed ID: 30858620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen presentation on MHC molecules as a diversity filter that enhances immune efficacy.
    van den Berg HA; Rand DA
    J Theor Biol; 2003 Sep; 224(2):249-67. PubMed ID: 12927531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
    Markovic-Plese S
    Neuroscientist; 2009 Jun; 15(3):225-31. PubMed ID: 19297658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated TCRs remain marked for internalization after dissociation from pMHC.
    Coombs D; Kalergis AM; Nathenson SG; Wofsy C; Goldstein B
    Nat Immunol; 2002 Oct; 3(10):926-31. PubMed ID: 12244312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of T cell function by TCR/pMHC binding kinetics.
    Carreño LJ; González PA; Kalergis AM
    Immunobiology; 2006; 211(1-2):47-64. PubMed ID: 16446170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminative T-cell receptor recognition of highly homologous HLA-DQ2-bound gluten epitopes.
    Dahal-Koirala S; Ciacchi L; Petersen J; Risnes LF; Neumann RS; Christophersen A; Lundin KEA; Reid HH; Qiao SW; Rossjohn J; Sollid LM
    J Biol Chem; 2019 Jan; 294(3):941-952. PubMed ID: 30455354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of public T cell responses.
    Li H; Ye C; Ji G; Han J
    Cell Res; 2012 Jan; 22(1):33-42. PubMed ID: 22212481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands.
    Zhao Y; Gran B; Pinilla C; Markovic-Plese S; Hemmer B; Tzou A; Whitney LW; Biddison WE; Martin R; Simon R
    J Immunol; 2001 Aug; 167(4):2130-41. PubMed ID: 11489997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis for self-recognition by autoimmune T-cell receptors.
    Yin Y; Li Y; Mariuzza RA
    Immunol Rev; 2012 Nov; 250(1):32-48. PubMed ID: 23046121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers.
    Zhang H; Liu L; Zhang J; Chen J; Ye J; Shukla S; Qiao J; Zhan X; Chen H; Wu CJ; Fu YX; Li B
    Clin Cancer Res; 2020 Mar; 26(6):1359-1371. PubMed ID: 31831563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo.
    Gottschalk RA; Corse E; Allison JP
    J Exp Med; 2010 Aug; 207(8):1701-11. PubMed ID: 20660617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Framework for Annotation of Antigen Specificities in High-Throughput T-Cell Repertoire Sequencing Studies.
    Pogorelyy MV; Shugay M
    Front Immunol; 2019; 10():2159. PubMed ID: 31616409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MHC Bias by T Cell Receptors: Genetic Evidence for MHC and TCR Coevolution.
    Baker BM; Evavold BD
    Trends Immunol; 2017 Jan; 38(1):2-4. PubMed ID: 27939452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.